Milan - from diabetes, digestive and kidney disease (NIDDK) National Institute studies have shown that patients with chronic hepatitis C virus (HCV) patients, daily consumption of more than 308 milligrams of caffeine, there will be minimal hepatic fibrosis. Study found that daily intake of caffeine equivalent to 2.25 cups of regular coffee is beneficial. In addition to coffee outside, from other sources of caffeine are not the same therapeutic effect.

The study of the specific content can be represented by the Wiley-Blackwell publication of the American Liver Association for the Study of Liver Diseases January 2010 issue of the magazine found.

Lead author Dr. Apurva Modi and his diabetes, digestive and kidney institute researchers to determine, for patients with chronic hepatitis C virus in patients, in addition to coffee outside, from other sources of caffeine not have the same therapeutic effect.

Liver fibrosis, liver disease or liver scarring is the second phase, the characteristic is due to accumulation of connective tissue, liver function degradation.

From January 2006 to November 2008, all liver diseases at the National Institutes of Health Division assessment of the patients were asked to complete a questionnaire to determine the caffeine consumption. Questions to ask about: the daily routine and soft drinks; ordinary and decaffeinated coffee; black tea, green tea, Chinese tea and herbal tea; cocoa and hot chocolate; caffeine enhanced beverages; chocolate candy; caffeine pills and with caffeine drugs.

The study suggested that about 2 cups of coffee consumed per day the amount of caffeine would have a beneficial effect, but soft drinks containing caffeine, green tea or black tea and reduced liver fibrosis and does not matter.